8 Results for "

PARP11

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "PARP11" in MCE Product Catalog:

  • Targets Recommended:
2
2 Cited Publications
Cat. No.: HY-148566
CAS No.: 943119-42-4
Purity:  99.86%
Target:  

PARP

Research Areas:  

Cancer

OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15. OUL232 is the most potent PARP10 inhibitor described to date (IC50=7.8 nM), as well as the first PARP12 inhibitor ever reported .
loading...
    loading...
Cat. No.: HY-125218
CAS No.: 2411890-36-1
Purity:  99.77%
Synonyms: ITK7
Target:  

PARP

Research Areas:  

Cancer

PARP11 inhibitor ITK7 (ITK7) is a potent and selective PARP11 inhibitor. PARP11 inhibitor ITK7 can potently inhibit PARP11 with an IC50 value of 14 nM. PARP11 inhibitor ITK7 can be used for the research of cellular localization .
loading...
    loading...
Cat. No.: HY-RS18009
Research Areas:  

Others

Parp11 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Parp11 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS10053
Research Areas:  

Others

PARP11 Human Pre-designed siRNA Set A contains three designed siRNAs for PARP11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24482
Research Areas:  

Others

Parp11 Rat Pre-designed siRNA Set A contains three designed siRNAs for Parp11 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-180926
Target:  

PARP

Research Areas:  

Cancer

PARP10-IN-4 (compound 12Z) is a potent PARP10 inhibitor with a pIC50 of 7.95. also shows inhibitory activity against TNKS1, TNKS2, and PARP11 with pIC50 values of 6.95, 7.03, and 7.01, respectively .
loading...
    loading...
Cat. No.: HY-162172
CAS No.: 2819999-00-1
Target:  

PARP

Research Areas:  

Cancer

PARP7-IN-18 is a potent, highly selective, and orally active PARP7 inhibitor with an IC50 of 0.11 nM. PARP7-IN-18 exhibits >1000-fold selectivity over other PARP family members. PARP7-IN-18 inhibits NCI-H1373 lung cancer cell proliferation with an IC50 of 2.5 nM and promotes IFN-β expression. PARP7-IN-18 exhibits favorable pharmacokinetic properties and can be used in research on PARP7-sensitive tumors, such as lung cancer .
loading...
    loading...
Cat. No.: HY-125217
CAS No.: 2286261-72-9
Target:  

PARP

Research Areas:  

Cancer

PARP10-IN-1 is a PARP10 inhibitor with an IC50 of 1.8 μM, 2.7 μM, and >10-fold selectivity over most PARP family members, excluding PARP7 and PARP16.PARP10-IN-1 inhibits PARP10-mediated mono-ADP-ribosylation, including auto-MARylation of PARP10 and MARylation of its protein targets.PARP10-IN-1 is membrane permeable and inhibits PARP10-dependent MARylation in human embryonic kidney cells.PARP10-IN-1 can be used for the research of cancer .
loading...
    loading...